{"publish_date":{"6338022":20141010,"6356546":20141010,"6348375":20141010},"url":{"6338022":"http:\/\/blogs.scientificamerican.com\/absolutely-maybe\/2014\/10\/10\/the-hepatitis-c-escalation-baby-boomer-ripple-effects\/","6356546":"http:\/\/www.usatoday.com\/story\/money\/business\/2014\/10\/10\/new-once-a-day-pill-for-hep-c-wins-fda-approval\/17040377\/","6348375":"http:\/\/www.tuscaloosanews.com\/article\/20141010\/NEWS\/141019933\/1001"},"topic":{"6338022":"hepat","6356546":"hepat","6348375":"hepat"},"model1_prediction":{"6338022":1,"6356546":1,"6348375":1},"model1_prediction_prob":{"6338022":0.5756869807,"6356546":0.5304794163,"6348375":0.5019391982},"title":{"6338022":"The Hepatitis C Escalation: Baby Boomer Ripple Effects","6356546":"New once-a-day pill for Hep C wins FDA approval","6348375":"New once-a-day pill for hepatitis C wins FDA OK"}}